BKV Corporation (BKV) - What Are Analysts Saying About This Stock?

Key Points

• Analysts are broadly positive: BKV has a “Moderate Buy” consensus from 11 analysts—eight Buy, one Strong Buy, and two Hold ratings—with an average 12-month price target of $33.33.
• Quarterly results were mixed: BKV reported earnings of $0.36 per share, below the $0.38 estimate, while revenue of $478.37 million exceeded expectations of $395.18 million.
• Insiders have been selling: Company insiders sold 40,578 shares worth about $1.0 million over the last 90 days; the transactions were made under pre-arranged trading plans.

Shares of BKV Corporation (NYSE:BKV - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eleven analysts that are presently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $33.33.

A number of equities analysts have weighed in on the stock. Wall Street Zen lowered shares of BKV from a "sell" rating to a "strong sell" rating in a research report on Saturday, October 17th. Susquehanna reduced their target price on shares of BKV from $37.00 to $35.00 and set a "positive" rating for the company in a research note on Tuesday, July 21st. Zacks Research lowered shares of BKV from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, November 4th. Raymond James Financial set a $29.00 price target on shares of BKV in a research note on Tuesday, September 15th. Finally, Evercore raised shares of BKV to a "strong-buy" rating in a report on Friday, September 18th.

BKV Stock Up 4.8%

BKV stock opened at $18.40 on Tuesday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.10 and a current ratio of 1.15. The company has a market capitalization of $2.01 billion, a price-to-earnings ratio of 8.72 and a beta of 1.13. BKV has a fifty-two week low of $17.47 and a fifty-two week high of $32.81. The stock has a fifty day moving average of $22.50 and a 200-day moving average of $26.29.

BKV (NYSE:BKV - Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.38 by ($0.02). BKV had a return on equity of 6.67% and a net margin of 17.73%. The firm had revenue of $478.37 million during the quarter, compared to analysts' expectations of $395.18 million. As a group, equities research analysts predict that BKV will post 1.47 earnings per share for the current year.

Insider Buying and Selling at BKV

In other BKV news, insider Lindsay Larrick sold 10,000 shares of the business's stock in a transaction on Friday, August 14th. The shares were sold at an average price of $26.16, for a total transaction of $261,600.00. Following the sale, the insider owned 83,925 shares of the company's stock, valued at $2,195,478. The trade was a 10.65% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David Tameron sold 1,500 shares of the stock in a transaction on Friday, August 21st. The stock was sold at an average price of $25.63, for a total value of $38,445.00. Following the sale, the chief financial officer owned 57,024 shares in the company, valued at approximately $1,461,525.12. This represents a 2.56% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 40,578 shares of company stock valued at $1,005,136 in the last 90 days. 2.51% of the stock is currently owned by company insiders.

Institutional Trading of BKV

Institutional investors have recently added to or reduced their stakes in the stock. Bank of New York Mellon Corp purchased a new stake in shares of BKV in the second quarter worth about $15,261,000. Value Aligned Research Advisors LLC boosted its position in shares of BKV by 110.5% in the second quarter. Value Aligned Research Advisors LLC now owns 679,899 shares of the company's stock valued at $18,602,000 after acquiring an additional 356,848 shares during the period. William Blair Investment Management LLC bought a new position in shares of BKV in the second quarter valued at approximately $32,689,000. TD Waterhouse Canada Inc. purchased a new position in BKV during the third quarter valued at approximately $1,227,000. Finally, SIR Capital Management L.P. purchased a new position in BKV during the second quarter valued at approximately $1,135,000.

BKV Company Profile

BKV Corporation is a U.S. energy company focused on natural gas production and related businesses. It operates in the Barnett Shale in Texas and the Marcellus Shale in Pennsylvania, producing natural gas for sale to customers and markets across the region.

The company has expanded beyond production into natural gas gathering and processing, natural gas-fired power generation, and carbon capture and sequestration. These activities connect its gas operations with energy delivery and projects intended to reduce emissions.

Founded as part of Thailand-based Banpu's U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.